Task: Answer the multiple choice question.
Question: Which drug exhibits a -5.458% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) COc1ccc(N/N=C(\C#N)C(N)=O)cc1
b) N#Cc1ccccc1Sc1ccccc1C(=O)Nc1ccc(Br)cc1
c) Cc1ccc(S(=O)(=O)Oc2ccc(/C=N/NC(=O)c3nn(C)cc3Cl)cc2)cc1
d) CCOc1ccc(C(=O)c2ccc(OCC)c(N)c2)cc1N
e) CCC(=O)Nc1cc(-c2nnc(OC)c3ccccc23)ccc1N1CCOCC1
Answer: e. CCC(=O)Nc1cc(-c2nnc(OC)c3ccccc23)ccc1N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1cc(-c2nnc(OC)c3ccccc23)ccc1N1CCOCC1
CCC(=O)Nc1cc(-c2nnc(OC)c3ccccc23)ccc1N1CCOCC1
N-[5-(4-methoxyphthalazin-1-yl)-2-morpholin-4-ylphenyl]propanamide